We are live on ! Find out more
FLACU

Frazier Lifesciences Acquisition Corporation Unit
FLACU

Delisted

FLACU was delisted on the 22nd of November, 2022.

Back to rankings

37 hedge funds and large institutions have $64.4M invested in Frazier Lifesciences Acquisition Corporation Unit in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 10

48% less capital invested

Capital invested by funds: $124M → $64.4M (-$59.2M)

48% less funds holding

Funds holding: 71 → 37 (-34)

89% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 38

Holders
37
Holders Change
-34
Holders Change %
-47.89%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
10
Closed
38
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$799K
2
WCMNY
Westchester Capital Management (New York)
New York
+$742K
3
BFM
Boothbay Fund Management
New York
+$140K
4
HF
HRT Financial
New York
+$125K
5
MA
MYDA Advisors
New York
+$110K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$7.42M
2
Citadel Advisors
Citadel Advisors
Florida
-$5.73M
3
DCM
DG Capital Management
New York
-$4.68M
4
SSA
Schonfeld Strategic Advisors
New York
-$4.3M
5
GL
Governors Lane
New York
-$4.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
WMSA
26
Weiss Multi-Strategy Advisers
New York
$164K -$205K -19,224 -54%
DIG
27
DeepCurrents Investment Group
New York
$152K +$46.5K +4,362 +41%
Walleye Trading
28
Walleye Trading
New York
$122K – – –
GCIA
29
Gabelli & Co Investment Advisers
New York
$104K – – –
EAM
30
Exos Asset Management
New York
$102K – – –
AM
31
Anqa Management
New York
$59K +$62K +5,815 New
UBS Group
32
UBS Group
Switzerland
$20K +$21.3K +1,999 New
Morgan Stanley
33
Morgan Stanley
New York
$5K +$3.94K +370 +370%
TRCT
34
Tower Research Capital (TRC)
New York
$5K +$4.69K +440 +1,467%
Osaic Holdings
35
Osaic Holdings
Arizona
$1K +$1.07K +100 New
Walleye Capital
36
Walleye Capital
New York
$183 – – –
Alyeska Investment Group
37
Alyeska Investment Group
Illinois
– -$7.42M -715,000 Closed
Citadel Advisors
38
Citadel Advisors
Florida
– -$5.73M -550,000 Closed
DCM
39
DG Capital Management
New York
– -$4.68M -450,000 Closed
SSA
40
Schonfeld Strategic Advisors
New York
– -$4.3M -414,300 Closed
GL
41
Governors Lane
New York
– -$4.15M -400,000 Closed
RCM
42
Radcliffe Capital Management
Pennsylvania
– -$2.6M -250,000 Closed
CCA
43
Castle Creek Arbitrage
Colorado
– -$2.1M -202,029 Closed
FTCM
44
Fir Tree Capital Management
New York
– -$2.08M -200,000 Closed
Hudson Bay Capital Management
45
Hudson Bay Capital Management
Connecticut
– -$2.08M -200,000 Closed
LA
46
Linden Advisors
New York
– -$2.08M -200,000 Closed
MI
47
MMCAP International
Cayman Islands
– -$2.08M -200,000 Closed
PAMP
48
Polar Asset Management Partners
Ontario, Canada
– -$2.08M -200,000 Closed
MIM
49
Monashee Investment Management
Massachusetts
– -$1.56M -150,000 Closed
PC
50
Periscope Capital
Ontario, Canada
– -$1.5M -144,072 Closed
1
2
3

FLACU Hedge Fund Activity: Q1 2021 in Review

37 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Unit (FLACU) for Q1 2021, worth a combined $64.4M — down 48% from $124M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of FLACU and 4 opened new positions — a net loss of 34 holders — while 10 trimmed existing stakes and 7 added.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $799K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $7.42M sold.

  • 37 institutional investors held Frazier Lifesciences Acquisition Corporation Unit (FLACU) as of Q1 2021, down from 71 in Q4 2020.
  • Funds reported $64.4M of Frazier Lifesciences Acquisition Corporation Unit stock for Q1 2021, down 48% quarter-over-quarter.
  • 4 funds opened new Frazier Lifesciences Acquisition Corporation Unit positions in Q1 2021 and 38 closed out, a net change of -34 holders.
  • The largest Frazier Lifesciences Acquisition Corporation Unit buyer in Q1 2021 was Ikarian Capital, an estimated $799K added.
  • The largest Frazier Lifesciences Acquisition Corporation Unit seller in Q1 2021 was Alyeska Investment Group, an estimated $7.42M sold.

Based on aggregated 13F filings for Q1 2021.